Young-aged group | |||
Characteristics | Class 1 (n = 112) | P value | |
OR | 95% C.I | ||
Medical insurance | |||
Employed health insurance | reference | ||
Urban health insurance | 0.97 | 0.46–2.04 | 0.934 |
Rural health insurance | 0.50 | 0.17–1.46 | 0.205 |
Without health insurance | 0.30 | 0.09–0.99 | 0.048 |
Chemotherapy cycles | |||
First cycle | reference | ||
Secondary cycle | 1.07 | 0.39–2.94 | 0.899 |
Third cycle | 0.57 | 0.19–1.66 | 0.299 |
Fourth cycle or above | 0.33 | 0.16–0.72 | 0.005 |
Middle-aged group | |||
Characteristics | Class 1 (n = 74) | P value | |
OR | 95% C.I | ||
Menstrual status | |||
Premenopausal | reference | ||
Menopausal | 3.58 | 1.69–7.59 | 0.001 |
Postmenopausal | 1.11 | 0.58–2.10 | 0.761 |
Elderly-aged group | |||
Characteristics | Class 1 (n = 68) | P value | |
OR | 95% C.I | ||
Complication | |||
No | reference | ||
Yes | 7.40 | 1.98–27.60 | 0.003 |